WallStreetZen

NASDAQ: AMGN
Amgen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AMGN

Based on 18 analysts offering 12 month price targets for Amgen Inc.
Min Forecast
$185.00-24.64%
Avg Forecast
$259.06+5.53%
Max Forecast
$304.00+23.83%

Should I buy or sell AMGN stock?

Buy
Strong Buy
8 analysts 36.36%
Buy
1 analysts 4.55%
Hold
12 analysts 54.55%
Sell
0 analysts 0%
Strong Sell
1 analysts 4.55%

Forecast return on equity

Is AMGN forecast to generate an efficient return?
Company
105.47%
Industry
74.22%
Market
62.25%
AMGN's Return on Equity is forecast to be high in 4 years (105.47%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AMGN forecast to generate an efficient return on assets?
Company
17.88%
Industry
16.87%
Market
19.66%
AMGN is forecast to generate higher Return on Assets (17.88%) than the US Drug Manufacturers - General industry average (16.87%)
Forecast

AMGN earnings per share forecast

What is AMGN's earnings per share in the next 3 years based on estimates from 14 analysts?
Avg 1 year Forecast
$17.00+36.07%
Avg 2 year Forecast
$18.53+48.33%
Avg 3 year Forecast
$18.92+51.46%
AMGN's earnings are forecast to grow at a rate of 15.38% per year, which is not exceptional
Forecast

AMGN revenue forecast

What is AMGN's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$26.2B+4.85%
Avg 2 year Forecast
$27.0B+8.06%
Avg 3 year Forecast
$27.7B+11.02%
AMGN's revenue is forecast to grow at a rate of 3.56% per year, which is not exceptional
Forecast

AMGN earnings growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
15.38%
Industry
24.82%
Market
20.47%
AMGN's earnings are forecast to grow slower (15.38% per year) than the US Drug Manufacturers - General industry average (24.82%)
Forecast
AMGN's earnings are forecast to grow slower (15.38% per year) than the US market average (20.47%)
Forecast
AMGN's earnings are forecast to grow faster (15.38% per year) than the risk-free savings rate (1.1%)
Forecast

AMGN revenue growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.56%
Industry
6.43%
Market
14.48%
AMGN's revenues are forecast to grow slower (3.56% per year) than the US Drug Manufacturers - General industry average (6.43%)
Forecast
AMGN's revenues are forecast to grow slower (3.56% per year) than the US market average (14.48%)
Forecast

Amgen Stock Forecast FAQ

Is Amgen Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 22 Wall Street analysts covering (NASDAQ: AMGN) stock is to Buy AMGN stock.

Out of 22 analysts, 8 (36.36%) are recommending AMGN as a Strong Buy, 1 (4.55%) are recommending AMGN as a Buy, 12 (54.55%) are recommending AMGN as a Hold, 0 (0%) are recommending AMGN as a Sell, and 1 (4.55%) are recommending AMGN as a Strong Sell.

What is AMGN's Price Target?

According to 18 Wall Street analysts that have issued a 1 year AMGN price target, the average AMGN price target is $259.06, with the highest AMGN stock price forecast at $304.00 and the lowest AMGN stock price forecast at $185.00.

On average, Wall Street analysts predict that Amgen's share price could reach $259.06 by Jan 13, 2022. The average Amgen stock price prediction forecasts a potential upside of 5.53% from the current AMGN share price of $245.49.

What is AMGN's earnings growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual earnings growth rate of 15.38% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 24.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.47%.

Amgen's earnings in 2020 is $7,352,000,000.On average, 14 Wall Street analysts forecast AMGN's earnings for 2021 to be $9,953,865,706, with the lowest AMGN earnings forecast at $9,353,529,587, and the highest AMGN earnings forecast at $10,583,486,514. On average, 10 Wall Street analysts forecast AMGN's earnings for 2022 to be $10,850,562,876, with the lowest AMGN earnings forecast at $9,786,942,980, and the highest AMGN earnings forecast at $12,141,431,956.

In 2023, AMGN is forecast to generate $11,079,627,711 in earnings, with the lowest earnings forecast at $10,202,785,561 and the highest earnings forecast at $11,854,442,006.

What is AMGN's revenue growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 3.56% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.48%.

Amgen's revenue in 2020 is $24,987,000,000.On average, 10 Wall Street analysts forecast AMGN's revenue for 2021 to be $15,345,107,207,441, with the lowest AMGN revenue forecast at $14,834,451,933,200, and the highest AMGN revenue forecast at $15,864,101,589,650. On average, 9 Wall Street analysts forecast AMGN's revenue for 2022 to be $15,813,695,611,986, with the lowest AMGN revenue forecast at $15,312,378,053,600, and the highest AMGN revenue forecast at $16,259,444,887,775.

In 2023, AMGN is forecast to generate $16,247,228,487,016 in revenue, with the lowest revenue forecast at $15,286,607,527,500 and the highest revenue forecast at $16,793,011,916,800.

What is AMGN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's current Earnings Per Share (EPS) is $12.49. On average, analysts forecast that AMGN's EPS will be $17.00 for 2021, with the lowest EPS forecast at $15.97, and the highest EPS forecast at $18.07. On average, analysts forecast that AMGN's EPS will be $18.53 for 2022, with the lowest EPS forecast at $16.71, and the highest EPS forecast at $20.73. In 2023, AMGN's EPS is forecast to hit $18.92 (min: $17.42, max: $20.24).

What is AMGN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AMGN) forecast ROE is 105.47%, which is considered strong.

What is AMGN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AMGN) forecast ROA is 17.88%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.87%.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics